Maryland Approves First Government-Plan Drug Payment Caps

Maryland has approved the nation’s first upper payment limits on high-cost prescription drugs for state and local government health plans, covering Ozempic and Jardiance. The limits are expected to take effect Jan. 1, 2027, and state officials estimate they could save government plans about $6.1 million; they cap what plans reimburse, not what drugmakers may charge. Supporters say the policy will ease costs for government plans, while pharmaceutical and patient advocacy groups warn that insurers or pharmacies could respond with tighter coverage rules or reduced access. The board says it will adjust the policy if access is harmed, and a 2025 law could allow the limits to extend to private insurance in 2028.



